Refer a friend
Refer a friend or family member to join research study today and you will receive a $55 Visa gift card when they enroll.
Pick a friend or a family member who is new to Charter Research.
Fill out the form below.
Fill Out The Form
Study
Early Alzheimer’s Study
Study participation helps move research forward.
Join an early-Alzheimer's study.
This study looks at an oral medication that’s taken daily, making it an easier and more convenient option for many people.
This study is only at Charter Research’s location in Chicago.
The purpose of this early Alzheimer’s disease (AD) study is to find out if the study drug can possibly prevent, delay, or modify symptoms of Alzheimer’s disease.
Amyloid beta and tau tangles are the most well known misshapen toxic proteins involved in AD, but there may be many more at work. This new investigational drug, taken orally as a capsule, may inhibit many different types of these toxic proteins. These proteins build up in the brain of those with Alzheimer’s and are theorized to be the engine driving the disease’s progression.
If this process can be slowed down or halted, the potential disease-modifying investigational drug could be a next step in fighting Alzheimer’s.
Who is eligible?
You may qualify for this study if:
- You are 55-85 years of age.
- You have a diagnosis of mild- to moderate-Alzheimer's disease.
- You can swallow capsules.
Sign Up
Schedule Your Assessment
Sign up for an initial assessment (called a “prescreen”), and we'll give you a call. One of our professional medical staff will answer your questions and give you more information about Charter Research prior to an in-office visit.
Get More Information
Location supporting this study
Chicago, IL
Hours of Operation
8AM to 5PM